peoplePerson
Solange Peters
Solange Peters is a lung cancer trialist and past ESMO President who led CheckMate 743 in mesothelioma.
Solange Peters heads medical oncology at CHUV Lausanne, led CheckMate 743 (nivolumab plus ipilimumab in mesothelioma), and served as ESMO President in 2020-2021.
Role
Head of Medical Oncology, Lausanne University Hospital (CHUV); ESMO President 2020-2021
Institution
Specialisms
Thoracic oncologyImmunotherapyMesothelioma
Profiles
| Title | Journal | Year |
|---|---|---|
| First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743) | Lancet | 2021 |